Dr. Xie Xin is an investment partner of Linghang New Territories, mainly focusing on innovative drug research and development including biological drugs, small molecule drugs and cell/gene therapy. Dr. Xie is also a researcher and doctoral supervisor of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and a national new drug screener. As deputy director of the center, Dr. Xie has participated in many new drug research and development work and is responsible for active compound discovery and pharmacological efficacy research. Dr. Xie is a recipient of the National Fund for Distinguished Young Scholars, a leading talent in scientific and technological innovation of the “Ten Thousand People Program” andappointed twice as national “973Chief Scientists”.
Dr. Xie has published more than 100 papers in well-known journals such as Nature Communications, Cell Research, and PNAS, and applied for more than 30 invention patents, and more than 10 patents have been authorized. Ms. Xie holds a bachelor’s degree in Chemistry from Peking University and a Ph.D. in Neuroscience from the University of Medicine and Dentistry of New Jersey, USA.